91ÉçÇø

Kevin Schwartzman

Ìý

Kevin Schwartzman MD, MPH, FRCPC
Professor of Medicine
Director, Respiratory Division
91ÉçÇø and 91ÉçÇø Health Centre
Centre for Outcomes Research and Evaluation
Research Institute of the 91ÉçÇø Health Centre
5252 boul. de Maisonneuve O., Room 3D.63
Montréal, Québec H4A 3S5ÌýCANADA

Phone:ÌýÌý514-934-1934, extensions 32560/32153
Fax:ÌýÌý514-843-2083
kevin.schwartzman [at] mcgill.ca

Research


Focus

Research focuses on the clinical and economic evaluation of interventions in tuberculosis and other respiratory diseases, including screening and treatment for TB infection, and the application of digital technologies to TB care.

Keywords

tuberculosis, epidemiology, public health, quality of life, cost-effectiveness,Ìýdigital adherence technologiesÌý

Selected Publications

Schwartzman K, Oxlade O, Barr RG, Grimard F, Acosta I, Baez J, Ferreira E, Melgen RE, Morose W, Cruz Salgado A, Jacquet V, Maloney S, Laserson K, Pablos-Mendez A, Menzies D.Ìý Domestic returns from investment in the control of tuberculosis in other countries.ÌýÌýNÌýEnglÌýJÌýMed2005; 353:1008-20.Ìý

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjee B, Wynne A,ÌýSchwartzman K.Ìý The impact of tuberculosis on health utility:Ìý A longitudinal cohort study.ÌýÌýQuality of Life Research. 2015 Jun; 24(6):1337-1349.ÌýÌý

Mullie GA,ÌýSchwartzman K, Zwerling A, N’DiayeÌýDS.Ìý Revisiting screening for latent tuberculosis infection in health care workers:Ìý A cost-effectiveness analysis.ÌýÌýBMC Medicine; 2017; 15:104.ÌýÌý

Cormier M,ÌýSchwartzman K, N'Diaye DS, Boone CE, dos Santos AM, Gaspar J, Cazabon D, Ghiasi M, Kahn R, Uppal A, Morris M, Oxlade O.Ìý Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review.ÌýLancet Global HealthÌý2019; 7: e68-80.Ìý Ìý

Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, Bastos M, Trajman A, Falzon D,ÌýSchwartzman K.Ìý Evaluating the potential costs and impacts of digital health technologies for tuberculosis treatment support.ÌýÌýEuropean Respiratory JournalÌý2018; 52: 1801363Ìý

N’Diaye DS, Nsengiyumva NP, Uppal A, Oxlade O, Alvarez GG,ÌýSchwartzman K.Ìý The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities.ÌýÌýBMC MedicineÌý2019; 17: 26.Ìý Ìý

Uppal A, Nsengiyumva NP, Signor C, Jean-Louis F, Rochette M, Snowball H, Etok S, Annanack D, Ikey J, Ahmad Khan F,ÌýSchwartzman K. Active screening for tuberculosis in high-incidence Inuit communities in Canada: a cost-effectiveness analysis.ÌýÌýCMAJÌý2021; 193: E1652-9.ÌýÌý

Nsengiyumva NP, Campbell JR, Oxlade O, Vesga JF, Lienhardt C, Trajman A, Falzon D, Den Boon S, Arinaminpathy N,ÌýSchwartzman K.Ìý Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.ÌýÌýPLOS MedicineÌý2022; 19(6):e1004032.Ìý PMID: 35696431ÌýÌý

External Links

Ìý

Back to top